CalciMedica, Inc. CALC
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -24.45% | -15.65% | -18.91% | 0.31% | 6.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.58% | -10.82% | -4.47% | 11.44% | 16.68% |
| Operating Income | 21.58% | 10.82% | 4.47% | -11.44% | -16.68% |
| Income Before Tax | -1.75% | -3.56% | -115.78% | -69.71% | -65.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.75% | -3.56% | -115.78% | -69.71% | -65.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.75% | -3.56% | -115.78% | -69.71% | -65.81% |
| EBIT | 21.58% | 10.82% | 4.47% | -11.44% | -16.68% |
| EBITDA | 21.52% | 10.77% | 4.44% | -11.51% | -16.74% |
| EPS Basic | 16.22% | 17.20% | -66.04% | -2.01% | 15.54% |
| Normalized Basic EPS | 16.22% | 17.20% | -66.04% | -2.01% | 15.54% |
| EPS Diluted | 15.46% | 16.43% | -65.83% | -1.98% | 15.53% |
| Normalized Diluted EPS | 15.61% | 16.57% | -65.99% | -1.98% | 15.56% |
| Average Basic Shares Outstanding | 19.97% | 25.11% | 33.47% | 51.37% | 64.79% |
| Average Diluted Shares Outstanding | 20.93% | 26.14% | 32.61% | 50.20% | 63.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |